Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market
Published in eyeforpharma February 2016 by Rachel Howard
How large is the opportunity for pharma and healthcare companies in Taiwan? The auto-complete options that pop up during Google searches offer revealing insights into a topic, in particular highlighting any areas of concern or uncertainty. . If you type “is Taiwan…” into Google, the top two auto-complete results that appear relate to the country’s ambiguous autonomous status Is Taiwan a country? Is Taiwan part of China? The third question is one which our Emerging Markets team regularly gets asked and forms the focus of this month’s article: Is Taiwan a developed country?
North Asia infographic
North Asia's largest markets; China, Hong Kong, Japan, South Korea and Taiwan, are home to more than 1.6 billion people and is a key global growth region. With pharmaceutical sales of more than $215bn, it is an attractive region for pharma, however one in which each market differs in terms of opportunities - and challenges.
Click here to view our latest infographic, which provides an overview of the five most-commonly researched, largest pharma markets in North Asia.
Find out more about our experience in emerging markets »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »